Cargando…

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation

BACKGROUND: Gypenosides (Gyps), the major botanical component of Gynostemma pentaphyllum, was found to up-regulate the farnesoid X receptor (FXR) in a mouse model of non-alcoholic steatohepatitis (NASH). However, the exact role of FXR and underlying mechanisms in Gyps-mediated effects on NASH remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongshan, Xi, Yingfei, Liu, Hongliang, Xin, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449333/ https://www.ncbi.nlm.nih.gov/pubmed/36091227 http://dx.doi.org/10.3389/fnut.2022.914079

Ejemplares similares

Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
por: Li, Hongshan, et al.
Publicado: (2020)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
por: Lee, Jin Ha, et al.
Publicado: (2020)

Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
por: Li, Hongshan, et al.
Publicado: (2023)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
por: Gay, Martha D., et al.
Publicado: (2022)

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
por: Paraiso, Ines L., et al.
Publicado: (2021)

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
por: Hu, Ying-Bin, et al.
Publicado: (2018)

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet
por: Kundu, Payel, et al.
Publicado: (2022)

Activation of farnesoid X receptor suppresses ER stress and inflammation via the YY1/NCK1/PERK pathway in large yellow croaker (Larimichthys crocea)
por: Du, Jianlong, et al.
Publicado: (2022)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
por: Manley, Sharon, et al.
Publicado: (2015)

Beneficial Activities of Alisma orientale Extract in a Western Diet-Induced Murine Non-Alcoholic Steatohepatitis and Related Fibrosis Model via Regulation of the Hepatic Adiponectin and Farnesoid X Receptor Pathways
por: Jeon, Seung Ho, et al.
Publicado: (2022)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Luteolin alleviates methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiome
por: Guo, Wei, et al.
Publicado: (2022)

Slowly Digestible Carbohydrate Diet Ameliorates Hyperglycemia and Hyperlipidemia in High-Fat Diet/Streptozocin-Induced Diabetic Mice
por: Chen, Yu-Zhong, et al.
Publicado: (2022)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Cooked Adzuki Bean Reduces High-Fat Diet-Induced Body Weight Gain, Ameliorates Inflammation, and Modulates Intestinal Homeostasis in Mice
por: Zhao, Qingyu, et al.
Publicado: (2022)

A protein- and fiber-rich diet with astaxanthin alleviates high-fat diet-induced obesity in beagles
por: Xue, Jinhua, et al.
Publicado: (2022)

Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity
por: Wang, Zi-Xuan, et al.
Publicado: (2022)

Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet
por: Lu, Yanliu, et al.
Publicado: (2018)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Enhanced Alcoholic Liver Disease in Mice with Intestine-specific Farnesoid X Receptor Deficiency
por: Huang, Mingxing, et al.
Publicado: (2020)

Sucralose consumption ameliorates high-fat diet-induced glucose intolerance and liver weight gain in mice
por: Pino-Seguel, Pamela, et al.
Publicado: (2022)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)

Amelioration of obesity-related metabolic disorders via supplementation of Caulerpa lentillifera in rats fed with a high-fat and high-cholesterol diet
por: Manoppo, Jeanette Irene Christiene, et al.
Publicado: (2022)

Black soybean seed coat polyphenol ameliorates the abnormal feeding pattern induced by high-fat diet consumption
por: Hironao, Ken-yu, et al.
Publicado: (2022)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review
por: Varkaneh, Hamed Kord, et al.
Publicado: (2022)

Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling
por: Hu, Yonghong, et al.
Publicado: (2022)

Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN
por: LIU, JUN, et al.
Publicado: (2014)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
por: Lu, Xiao-Ting, et al.
Publicado: (2022)

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
por: Pichon, Camille, et al.
Publicado: (2022)

Molecular tuning of farnesoid X receptor partial agonism
por: Merk, Daniel, et al.
Publicado: (2019)

Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)

Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
por: Wu, Jin-nan, et al.
Publicado: (2020)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
por: Rausch, Magdalena, et al.
Publicado: (2022)

Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE(−/−) Mice
por: Gao, Ming, et al.
Publicado: (2022)

Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice
por: Zhao, Ting Ting, et al.
Publicado: (2015)

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lt0j75ktlf29ih2nlb953nlo7k